The Department of Industrial Policy and Promotion ('DIPP') has amended the existing Foreign Direct Investment ('FDI') policy for Pharmaceutical sector by segregating the same into greenfield and brownfield projects.
The revised FDI Policy provides as under:
Greenfield investments in the pharmaceuticals sector: 100% FDI permitted under automatic route
Brownfield investments (i.e. investments in existing companies), in the pharmaceuticals sector:100% FDI permitted under the Government route i.e. with the prior approval of Foreign Investment and Promotion Board ('FIPB')
by
Praveen Boda
No comments:
Post a Comment